Park West Asset Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-344,468
Closed -$6.39M 44
2024
Q1
$6.39M Buy
+344,468
New +$6.02M 0.45% 36
2023
Q4
Sell
-2,014,954
Closed -$27.8M 40
2023
Q3
$27.8M Sell
2,014,954
-66,129
-3% -$1.04M 2.56% 14
2023
Q2
$46M Buy
2,081,083
+627,954
+43% +$13.2M 4.03% 8
2023
Q1
$31.6M Buy
1,453,129
+502,143
+53% +$11.3M 2.82% 10
2022
Q4
$17.3M Buy
+950,986
New +$19.6M 1.69% 20
2020
Q4
Sell
-966,045
Closed -$28M 127
2020
Q3
$28M Buy
966,045
+197,195
+26% +$4.26M 1.08% 35
2020
Q2
$12.6M Sell
768,850
-210,556
-21% -$2.9M 0.62% 45
2020
Q1
$9.3M Buy
979,406
+108,495
+12% +$1.49M 0.63% 43
2019
Q4
$14.1M Buy
870,911
+81,145
+10% +$1.32M 0.59% 47
2019
Q3
$13.1M Buy
789,766
+445,511
+129% +$8.36M 0.64% 43
2019
Q2
$5.83M Buy
344,255
+323,731
+1,577% +$5.64M 0.24% 63
2019
Q1
$367K Buy
+20,524
New +$326K 0.02% 89

Other funds holding BLFS

Park West Asset Management's BLFS Position: Q2 2024 in Review

Park West Asset Management sold out of BioLife Solutions (BLFS) in Q2 2024, closing a stake of 344,468 shares — an estimated $6.39M sold.

Park West Asset Management first reported a position in BLFS in Q1 2019 and held it in 12 quarters. The position peaked at $46M in Q2 2023. 164 funds tracked by Wall St. Rank hold BLFS as of Q2 2024.

  • Park West Asset Management reported no remaining BioLife Solutions position as of Q2 2024 after selling out during the quarter.
  • Park West Asset Management sold 344,468 BioLife Solutions shares in Q2 2024, an estimated $6.39M.
  • Park West Asset Management first reported a position in BioLife Solutions in Q1 2019 and held it in 12 quarters.
  • Park West Asset Management's BioLife Solutions position peaked at $46M in Q2 2023.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2024.

Based on Park West Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.